Displaying 1 - 5 of 57
Tue 20 August 2019
Chris Macdonald, Head of Research at Pancreatic Cancer UK comments on a new pancreatic cancer drug showing improvement in patient survival in early-stage clinical trial at The University of Michigan Rogel Cancer Center.Read More about 'New drug shows promising early results for pancreatic cancer patients'
Pancreatic Cancer UK funds innovative exercise programme in Northern Ireland through Research Innovation fundThu 18 July 2019Pancreatic Cancer UK has awarded Queen’s University Belfast a £100,000 grant to trial an innovative new exercise programme to help panreatic cancer patients recover from surgery.Read More about 'Pancreatic Cancer UK funds innovative exercise programme in Northern Ireland through Research Innovation fund'
Thu 27 June 2019
Our Head of Research, Chris Macdonald, comments on new research suggesting that the protein, CA19-9, is involved in the development of pancreatic cancer.Read More about 'New research into the protein CA19-9 and pancreatic cancer'
Wed 01 May 2019
Just one in ten GPs say they have the tools they need to diagnose pancreatic cancer early enough for treatment to be possible, according to new polling, for Pancreatic Cancer UK.Read More about 'Only one in ten GPs have the tools needed to diagnose pancreatic cancer in time to treat'
New research from the Mayo Clinic identified 3 factors that significantly affected survival for pancreatic cancer patientsTue 02 April 2019We comment on new research from the Mayo Clinic which identified three factors that significantly affected survival for pancreatic cancer patients.Read More about 'New research from the Mayo Clinic identified 3 factors that significantly affected survival for pancreatic cancer patients'